I am a surgical oncologist treating patients with soft tissue sarcomas. I have specific expertise with gastrointestinal stromal tumors, Kaposi sarcoma, spine sarcoma and myxosarcoma. The OSUCCC – James is a remarkably collaborative and collegial environment, and our patients are always our top priority. I’m honored to be part of this world-class organization with the shared vision of a cancer-free world. I was named to the Castle Connolly list of “America's Top Doctors” from 2004-2018 and rated in the top 10 percent of physicians in the nation for patient satisfaction in 2017.
I serve as director of The Ohio State University Comprehensive Cancer Center, vice chair for clinical affairs at the OSUCCC – James, surgeon-in-chief for the OSUCCC – James, as well as surgeon-in-chief for The Ohio State University Health Care System, and professor in Ohio State’s division of surgical oncology. I’m also the director of the Sarcoma Research Laboratory at Ohio State.
Research has been an important part of my career. I have been entrusted to run many research efforts, including a recent $15 million Specialized Program of Research Excellence (SPORE) grant with the National Cancer Institute (NCI) that targets some of the most difficult-to-treat forms of sarcoma. We are driven every day knowing that time is of the essence for cancer patients and their families.
To stay involved with the latest cutting-edge therapies, I serve as chair of the American Joint Committee on Cancer’s Sarcoma Committee, and as a member of the advisory boards of the Sarcoma Foundation of America, the UICC TNM Expert Advisory Panel on Sarcoma, and the Bone and Soft Tissue Cancer Protocol Review Panel of the College of American Pathologists.